Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In Vitro Copper tripeptide (1 nM
S2CID 24373303
This work was financially supported in part by National Institutes of Health awards U01HG011715, R01HG009120 and R01MH115676
Discover More insights in our report- Email: [email protected] | Call: United States +1-252-477-1362 | United Kingdom +44-203-957-8553 / +44-203-949-5508 | Australia +61-8-7924-7805 | India +91-848-285-0837 #AntidiureticDrugs #Desmopressin #Vasopressin #PharmaceuticalIndustry #DiabetesInsipidus #MarketResearch #CoherentMarketInsights To view or add a comment, sign in Azetukalner (XEN1101) (also known as encukalner) is an investigational anti-seizure medication being developed by Xenon Pharmaceuticals
